Cargando…
What Could be the Most Advantageous Therapeutic Approach to Avoid both Arterial and Venous Thrombosis in Hyperhomocysteinemia?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bentham Science Publishers
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226209/ https://www.ncbi.nlm.nih.gov/pubmed/32392117 http://dx.doi.org/10.2174/1573403X16666200511085701 |
| _version_ | 1783712239978545152 |
|---|---|
| author | Cacciapuoti, Federico |
| author_facet | Cacciapuoti, Federico |
| author_sort | Cacciapuoti, Federico |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8226209 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Bentham Science Publishers |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82262092022-03-01 What Could be the Most Advantageous Therapeutic Approach to Avoid both Arterial and Venous Thrombosis in Hyperhomocysteinemia? Cacciapuoti, Federico Curr Cardiol Rev Article Bentham Science Publishers 2021-03 2021-03 /pmc/articles/PMC8226209/ /pubmed/32392117 http://dx.doi.org/10.2174/1573403X16666200511085701 Text en © 2021 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
| spellingShingle | Article Cacciapuoti, Federico What Could be the Most Advantageous Therapeutic Approach to Avoid both Arterial and Venous Thrombosis in Hyperhomocysteinemia? |
| title | What Could be the Most Advantageous Therapeutic Approach to Avoid both Arterial and Venous Thrombosis in Hyperhomocysteinemia? |
| title_full | What Could be the Most Advantageous Therapeutic Approach to Avoid both Arterial and Venous Thrombosis in Hyperhomocysteinemia? |
| title_fullStr | What Could be the Most Advantageous Therapeutic Approach to Avoid both Arterial and Venous Thrombosis in Hyperhomocysteinemia? |
| title_full_unstemmed | What Could be the Most Advantageous Therapeutic Approach to Avoid both Arterial and Venous Thrombosis in Hyperhomocysteinemia? |
| title_short | What Could be the Most Advantageous Therapeutic Approach to Avoid both Arterial and Venous Thrombosis in Hyperhomocysteinemia? |
| title_sort | what could be the most advantageous therapeutic approach to avoid both arterial and venous thrombosis in hyperhomocysteinemia? |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226209/ https://www.ncbi.nlm.nih.gov/pubmed/32392117 http://dx.doi.org/10.2174/1573403X16666200511085701 |
| work_keys_str_mv | AT cacciapuotifederico whatcouldbethemostadvantageoustherapeuticapproachtoavoidbotharterialandvenousthrombosisinhyperhomocysteinemia |